|
|
Sold Out
Book Categories |
| Preface | ||
| Acknowledgments | ||
| 1 | A Birth Defect Child Is Born | 1 |
| 2 | Locating Bendectin Within the Mass Toxic Landscape | 4 |
| 3 | The Science of Determining Toxic Causation | 26 |
| 4 | The Food and Drug Administration | 41 |
| 5 | The Wm. S. Merrell Company | 61 |
| 6 | A Mother's Quest | 96 |
| 7 | The Mekdeci Case | 121 |
| 8 | The Unraveling of Mekdeci | 148 |
| 9 | The Proliferation of Bendectin Litigation | 159 |
| 10 | Litigating a Multidistrict Case | 167 |
| 11 | The Withdrawal of Bendectin | 180 |
| 12 | Forging a Mass Toxic Substances Trial | 189 |
| 13 | The Settlement and Unsettlement of MDL-486 | 207 |
| 14 | The MDL-486 Trial | 226 |
| 15 | Aggregative Procedure in Mass Toxic Substances Litigation | 237 |
| 16 | The Third Phase of Bendectin Litigation: Oxendine Richardson, and the Individual Trials | 273 |
| 17 | The Legacy of Bendectin for Toxic Causation Law | 299 |
| 18 | The Lessons and Non-Lessons of Bendectin Litigation | 328 |
| Selected Bibliography | 353 | |
| Index | 361 |
| Price | Condition | Delivery | Seller | Action |
| $99.99 | Digital |
| WonderClub |
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish List
X
This item is in your Collection
Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation
X
This Item is in Your Inventory
Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation
X
You must be logged in to review the productsX
X
X
Add Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation, Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a lis, Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation to the inventory that you are selling on WonderClubX
X
Add Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation, Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a lis, Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation to your collection on WonderClub |